Gilead
 
Media FAQ

Gilead-at-a-Glance

At Gilead, we are dedicated to advancing the care of patients suffering from life-threatening diseases worldwide. Our primary areas of focus currently include: HIV/AIDS, chronic hepatitis, cardiopulmonary conditions and respiratory diseases.

Worldwide Operations

Today, we have more that 2,700 employees and operations in North America and several countries throughout Europe and Australia.

Following are answers to some of the common questions most asked by journalists. For more information about our work, please visit the pages on this site focused on our products, mission and corporate responsibility initiatives.

Q: What is Gilead?
A: Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet need.

Q: How many products does Gilead currently market?
A: Our product portfolio is currently comprised of more than 10 marketed treatments, these include a number of category firsts and market leaders, such as Atripla™ – the first one-pill-a-day treatment regimen for HIV infection.

Q: How large is Gilead?
A: Gilead has more than 2,700 employees.

Q: Are logos and photos of Gilead and Gilead’s products available?
A: Photos and logos of Gilead and our products are available. We ask that you make your request by contacting the Public Affairs office at (650) 574-3000 or via email at public_affairs@gilead.com.

Q: Do you have b-roll and manufacturing footage available?
A: Yes, we have broadcast-quality b-roll available for journalists. We ask that you make your request by contacting the Public Affairs office at (650) 574-3000 or via email at public_affairs@gilead.com.

Q: Where is Gilead's headquarters?
A: Gilead's headquarters are located at 333 Lakeside Drive, Foster City, CA, 94404. The main phone number is (800) 445-3235 or (650) 574-3000.

Q: I’m working on a story about Gilead and would like to arrange an interview with a Gilead spokesperson. How do I go about that?
A: Please contact Gilead’s Public Affairs office at (650) 574-3000 or via email at public_affairs@gilead.com.

Q: Where is Gilead incorporated?
A: Gilead is incorporated in the State of Delaware.

Q: When did Gilead go public?
A: Gilead went public in January 1992.

Q: What were the company's total sales in 2006? R&D investments? Net income?
A: Total net product sales in 2006 were $2.59 billion. R&D investments were $383.9 million. Non-GAAP net income was $1.20 billion, or $2.52 per diluted share.